1. Case report: Durable response to afatinib in a patient with lung cancer harboring two uncommon mutations of EGFR and a KRAS mutation. (November 2016) Authors: Tanizaki, Junko; Banno, Eri; Togashi, Yosuke; Hayashi, Hidetoshi; Sakai, Kazuko; Takeda, Masayuki; Kaneda, Hiroyasu; Nishio, Kazuto; Nakagawa, Kazuhiko Journal: Lung cancer Issue: Volume 101(2016) Page Start: 11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Case report: Durable response to afatinib in a patient with lung cancer harboring two uncommon mutations of EGFR and a KRAS mutation. (November 2016) Authors: Tanizaki, Junko; Banno, Eri; Togashi, Yosuke; Hayashi, Hidetoshi; Sakai, Kazuko; Takeda, Masayuki; Kaneda, Hiroyasu; Nishio, Kazuto; Nakagawa, Kazuhiko Journal: Lung cancer Issue: Volume 101(2016) Page Start: 11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Disseminated intravascular coagulation induced by pazopanib following combination therapy of nivolumab plus ipilimumab in a patient with metastatic renal cell carcinoma. Issue 1 (January 2022) Authors: Hashimoto, Mamoru; Nakayama, Takahito; Fujimoto, Saizo; Inoguchi, Shunsuke; Nishimoto, Mitsuhisa; Kikuchi, Takashi; Adomi, Shogo; Banno, Eri; De Velasco, Marco A.; Saito, Yoshitaka; Shimizu, Nobutaka; Mori, Yasunori; Minami, Takafumi; Fujita, Kazutoshi; Nozawa, Masahiro; Nose, Kazuhiro; Yoshimura... Journal: Anti-cancer drugs Issue: Volume 33:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib. Issue 11 (November 2016) Authors: Hibi, Masaaki; Kaneda, Hiroyasu; Tanizaki, Junko; Sakai, Kazuko; Togashi, Yosuke; Terashima, Masato; De Velasco, Marco Antonio; Fujita, Yoshihiko; Banno, Eri; Nakamura, Yu; Takeda, Masayuki; Ito, Akihiko; Mitsudomi, Tetsuya; Nakagawa, Kazuhiko; Okamoto, Isamu; Nishio, Kazuto Journal: Cancer science Issue: Volume 107:Issue 11(2016) Page Start: 1667 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Gut microbiome and prostate cancer. (6th April 2022) Authors: Fujita, Kazutoshi; Matsushita, Makoto; Banno, Eri; De Velasco, Marco A; Hatano, Koji; Nonomura, Norio; Uemura, Hirotsugu Journal: International journal of urology Issue: Volume 29:Number 8(2022) Page Start: 793 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. MP38-14 GUT MICROBIOME ASSOCIATED WITH BLOOD TESTOSTERONE LEVELS IN ELDERLY MEN. (May 2022) Authors: Fujita, Kazutoshi; Matsushita, Makoto; Hatano, Koji; Nishimoto, Mitsuhisa; Motooka, Daisuke; Banno, Eri; Hata, Junya; Minami, Takafumi; Nozawa, Masahiro; Nakamura, Shota; Tsujimura, Akira; Obara, Wataru; Yoshimura, Kazuhiro; Uemura, Hirotsugu; Nonomura, Norio Journal: Journal of urology Issue: Volume 207(2022)Supplement 5 Page Start: e623 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon epidermal growth factor receptor mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor?. Issue 8 (14th July 2016) Authors: Banno, Eri; Togashi, Yosuke; Nakamura, Yu; Chiba, Masato; Kobayashi, Yoshihisa; Hayashi, Hidetoshi; Terashima, Masato; de Velasco, Marco A.; Sakai, Kazuko; Fujita, Yoshihiko; Mitsudomi, Tetsuya; Nishio, Kazuto Journal: Cancer science Issue: Volume 107:Issue 8(2016) Page Start: 1134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Significance of FGF9 gene in resistance to anti‐EGFR therapies targeting colorectal cancer: A subset of colorectal cancer patients with FGF9 upregulation may be resistant to anti‐EGFR therapies. Issue 1 (24th February 2016) Authors: Mizukami, Takuro; Togashi, Yosuke; Naruki, Saeko; Banno, Eri; Terashima, Masato; de Velasco, Marco A.; Sakai, Kazuko; Yoneshige, Azusa; Hayashi, Hidetoshi; Fujita, Yoshihiko; Tomida, Shuta; Nakajima, Takako Eguchi; Fujino, Takashi; Boku, Narikazu; Ito, Akihiko; Nakagawa, Kazuhiko; Nishio, Kazuto Journal: Molecular carcinogenesis Issue: Volume 56:Issue 1(2017:Jan.) Page Start: 106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Telomerase reverse transcriptase promoter mutation in tumorigenesis of bladder cancer: Evolutionary trajectory by algorithmic inference from cross‐sectional data. (15th April 2021) Authors: Hayashi, Yujiro; Fujita, Kazutoshi; Banno, Eri; Eich, Marie‐Lisa; Netto, George J; Nonomura, Norio Journal: International journal of urology Issue: Volume 28:Number 7(2021) Page Start: 774 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The Firmicutes/Bacteroidetes ratio of the human gut microbiota is associated with prostate enlargement. Issue 16 (13th September 2021) Authors: Takezawa, Kentaro; Fujita, Kazutoshi; Matsushita, Makoto; Motooka, Daisuke; Hatano, Koji; Banno, Eri; Shimizu, Nobutaka; Takao, Tetsuya; Takada, Shingo; Okada, Koichi; Fukuhara, Shinichiro; Kiuchi, Hiroshi; Uemura, Hirotsugu; Nakamura, Shota; Kojima, Yoshiyuki; Nonomura, Norio Journal: Prostate Issue: Volume 81:Issue 16(2021) Page Start: 1287 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗